Showing results (131-140 of 238) with videos related to

Sort By:
Pageof 24
European Journal of Endocrinology|March 5, 2005
The 'bio-assay' quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrationsIngrid E Bonapart, Ron van Domburg, Saskia M T H ten Have, et al.
Neuroendocrinology|November 5, 2015
Is There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?Roxanne C S van Adrichem, Kimberly Kamp, Carolien H M van Deurzen, et al.
Endocrine-Related Cancer|April 3, 2019
Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumorsAura D Herrera-Martínez, Rosanna van den Dungen, Fadime Dogan-Oruc, et al.
Neoplasia (New York, N.Y.)|November 8, 2014
Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndromeEsther Korpershoek, Bart-Jeroen Petri, Edward Post, et al.
Endocrine-Related Cancer|March 23, 2023
Proteomic analysis of small intestinal neuroendocrine tumors and mesenteric fibrosisAnela Blažević, Anand M Iyer, Marie-Louise F van Velthuysen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 24, 2013
Hypocalcaemia after treatment with [177Lu-DOTA 0,Tyr3]octreotateEsther I van Vliet, Wouter W de Herder, Yolanda B de Rijke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 5, 2017
Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine TumorsHendrik Bergsma, Kirsten van Lom, Marc H G P Raaijmakers, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Dopamine receptor expression and function in corticotroph pituitary tumorsRosario Pivonello, Diego Ferone, Wouter W de Herder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2022
Efficacy and safety of peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningiomaNoémie S Minczeles, Eelke M Bos, Reinoud C de Leeuw, et al.
Endocrine-Related Cancer|April 20, 2026
Unravelling Mesenteric Fibrosis in Small Intestinal Neuroendocrine Tumours and Implications for Clinical ManagementMaria Castanho Martins, Eva van der Slik, Johannes Hofland, et al.
Pageof 24